{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:58:40Z","timestamp":1761170320704,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1U54HD071594"],"award-info":[{"award-number":["1U54HD071594"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.prostaglandins.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T13:33:59Z","timestamp":1509024839000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Intermittent hypoxia alters dose dependent caffeine effects on renal prostanoids and receptors in neonatal rats"],"prefix":"10.1016","volume":"134","author":[{"given":"Kay D.","family":"Beharry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kultida","family":"Soontarapornchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taimur","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria B.","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob V.","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0022-3476(77)80718-X","article-title":"Efficacy of caffeine in treatment of apnea in the low-birth-weight infant","volume":"90","author":"Aranda","year":"1977","journal-title":"J. Pediatr."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0010","doi-asserted-by":"crossref","first-page":"F499","DOI":"10.1136\/adc.2002.023432","article-title":"& Caffeine Collaborative Study Group Steering Group: high dose caffeine citrate for extubation of preterm infants: a randomised controlled trial","volume":"89","author":"Steer","year":"2004","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0015","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"NEJM"},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0020","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"NEJM"},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000360647","article-title":"Caffeine for apnea of prematurity: a neonatal success story","volume":"105","author":"Kreutzer","year":"2014","journal-title":"Neonatology"},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0030","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1056\/NEJMe068028","article-title":"Caffeine for apnea of prematurity","volume":"354","author":"Bancalari","year":"2006","journal-title":"NEJM"},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00128072-200103010-00005","article-title":"Caffeine citrate: a review of its use in apnoea of prematurity","volume":"3","author":"Comer","year":"2001","journal-title":"Paediatr. Drugs"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.10.004_bib0040","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.3390\/ijms18010187","article-title":"Neuroprotection by caffeine in hyperoxia-induced neonatal brain injury","volume":"18","author":"Endesfelder","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","article-title":"A higher incidence of intermittent hypoxemia episodes is associated with severe retinopathy of prematurity","volume":"157","author":"Di Fiore","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/152308604771978471","article-title":"Free radicals and diseases in premature infants","volume":"6","author":"O\u2019Donovan","year":"2004","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0055","doi-asserted-by":"crossref","first-page":"2768365","DOI":"10.1155\/2016\/2768365","article-title":"Oxidative stress related diseases in newborns","author":"Ozsurekci","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"issue":"13","key":"10.1016\/j.prostaglandins.2017.10.004_bib0060","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1089\/ars.2013.5785","article-title":"Role of reactive oxygen species in neonatal pulmonary vascular disease","volume":"21","author":"Wedgwood","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.10.004_bib0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MOP.0b013e3283423e51","article-title":"Future applications of antioxidants in premature infants","volume":"23","author":"Lee","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.10.004_bib0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/ijerph2006030035","article-title":"Free radicals: emerging challenge in environmental health research in childhood and neonatal disorders","volume":"3","author":"Sharda","year":"2006","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"5-6","key":"10.1016\/j.prostaglandins.2017.10.004_bib0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0748-5514(86)80038-1","article-title":"Oxidant-mediated lung disease in newborn infants","volume":"2","author":"Evans","year":"1986","journal-title":"J. Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.10.004_bib0080","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/oxfordjournals.bmb.a072639","article-title":"Free radical disorders of preterm infants","volume":"49","author":"Kelly","year":"1993","journal-title":"Br. Med. Bull."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.10.004_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00001703-200104000-00009","article-title":"Update on oxygen radical disease in neonatology","volume":"13","author":"Saugstad","year":"2001","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0278-6915(91)90056-D","article-title":"Antioxidant behaviour of caffeine: efficient scavenging of hydroxyl radicals","volume":"29","author":"Shi","year":"1991","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0005-2736(96)00040-5","article-title":"Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species","volume":"1282","author":"Devasagayam","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lfs.2013.12.002","article-title":"Caffeine supplementation modulates oxidative stress markers in the liver of trained rats","volume":"96","author":"Barcelos","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0105","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1542\/peds.76.5.834","article-title":"Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding","volume":"76","author":"Le Guennec","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s002280050276","article-title":"Population pharmacokinetics of caffeine in premature neonates","volume":"52","author":"Falc\u00e3o","year":"1997","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000243252","article-title":"Renal effects of caffeine in preterm infants","volume":"58","author":"Gillot","year":"1990","journal-title":"Biol. Neonate"},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.10.004_bib0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.22.6.847","article-title":"Caffeine attenuates the renal vascular response to angiotensin II infusion","volume":"22","author":"Brown","year":"1993","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.10.004_bib0125","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1046\/j.1523-1755.2002.00278.x","article-title":"Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-fa(cp)) rats","volume":"61","author":"Tofovic","year":"2002","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.10.004_bib0130","first-page":"509","article-title":"Effect of acetylsalicylic acid, paracetamol, caffeine and a combination of these substances on the renal prostaglandin E2, 6-keto-prostaglandin F1 alpha, water, creatinine and electrolyte excretion of the rat","volume":"46","author":"Engelhardt","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0135","first-page":"39","article-title":"Prostaglandins and renal function","volume":"33","author":"McGiff","year":"1974","journal-title":"Fed. Proc."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.10.004_bib0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1054\/plef.2002.0444","article-title":"Role of renal PGE2 in the adaptation from foetal to extrauterine life in term and preterm infants","volume":"67","author":"Agostiniani","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.10.004_bib0145","first-page":"12","article-title":"Prostaglandins and the developing kidney","volume":"11","author":"Gleason","year":"1987","journal-title":"Semin. Perinatol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.10.004_bib0150","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ki.1981.78","article-title":"Metabolism of prostaglandins in the kidney","volume":"19","author":"Sun","year":"1981","journal-title":"Kidney Int."},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2017.10.004_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2007.04.006","article-title":"Urinary prostaglandin E2 in the newborn and infant","volume":"84","author":"Antonucci","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0160","first-page":"F643","article-title":"Evidence that separate PGE2 receptors modulate water and sodium transport in rabbit cortical collecting duct","volume":"265","author":"Hebert","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.physiol.63.1.579","article-title":"G protein-coupled prostanoid receptors and the kidney","volume":"63","author":"Breyer","year":"2001","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0170","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1152\/ajprenal.2000.279.1.F12","article-title":"E receptors and the kidney","volume":"279","author":"Breyer","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"41","key":"10.1016\/j.prostaglandins.2017.10.004_bib0175","doi-asserted-by":"crossref","first-page":"35028","DOI":"10.1074\/jbc.M505852200","article-title":"Characterization of a rabbit kidney prostaglandin F(2{alpha}) receptor exhibiting G(i)-restricted signaling that inhibits water absorption in the collecting duct","volume":"280","author":"H\u00e9bert","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0180","first-page":"F1164","article-title":"Expression of the prostaglandin F receptor (FP) gene along the mouse genitourinary tract","volume":"284","author":"Saito","year":"2003","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.10.004_bib0185","doi-asserted-by":"crossref","first-page":"F689","DOI":"10.1152\/ajprenal.00020.2002","article-title":"Localization of IP in rabbit kidney and functional role of the PGI(2)\/IP system in cortical collecting duct","volume":"283","author":"Nasrallah","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"156","key":"10.1016\/j.prostaglandins.2017.10.004_bib0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0002-9378(87)90340-1","article-title":"Dose-dependent effects of prostaglandin D2 on hemodynamics renal function, and blood gas analyses","volume":"1987","author":"Rao","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.10.004_bib0195","first-page":"168","article-title":"Prostaglandins, the kidney, and hypertension","volume":"153","author":"Wilson","year":"1990","journal-title":"West. J. Med."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.10.004_bib0200","first-page":"185","article-title":"Aquaglyceroporins in the kidney: present state of knowledge and prospects","volume":"67","author":"Michalek","year":"2016","journal-title":"J. Physiol. Pharmacol."},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.10.004_bib0205","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1097\/01.ASN.0000089566.28106.F6","article-title":"Aquaporin expression in normal human kidney and in renal disease","volume":"14","author":"Bedford","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.10.004_bib0210","first-page":"385","article-title":"Intermittent hypoxia-induced renal antioxidants and oxidative damage in male mice: hormetic dose response","volume":"11","author":"Sun","year":"2012","journal-title":"Dose Response"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.10.004_bib0215","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/pr.2016.105","article-title":"Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy","volume":"80","author":"Aranda","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0220","first-page":"7644","article-title":"Hydrogen peroxide accumulation in the choroid during intermittent hypoxia increases risk of severe oxygen-induced retinopathy in neonatal rats","volume":"54","author":"Beharry","year":"2013","journal-title":"IOVS"},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0225","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1021\/pr501238m","article-title":"Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach","volume":"14","author":"Tu","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/j.sempedsurg.2013.10.008","article-title":"Neonatal renal physiology","volume":"22","author":"Sulemanji","year":"2013","journal-title":"Semin. Pediatr. Surg."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0235","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1203\/PDR.0b013e31820b95ca","article-title":"Acute kidney injury reduces survival in very low birth weight infants","volume":"69","author":"Koralkar","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpeds.2016.01.051","article-title":"Caffeine exposure and risk of acute kidney injury in a retrospective cohort of very low birth weight neonates","volume":"172","author":"Carmody","year":"2016","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.10.004_bib0245","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/j.2040-4603.2012.tb00431.x","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Comp. Physiol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.10.004_bib0250","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.kint.2015.11.021","article-title":"Autophagy in acute kidney injury","volume":"89","author":"Kaushal","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/FTD.0b013e3181898b6f","article-title":"Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring","volume":"30","author":"Charles","year":"2008","journal-title":"Ther. Drug Monit."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.10.004_bib0260","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/01.tp.0000287334.38933.e3","article-title":"Bcl-xL augmentation potentially reduces ischemia\/reperfusion induced proximal and distal tubular apoptosis and autophagy","volume":"84","author":"Chien","year":"2007","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.10.004_bib0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5049\/EBP.2008.6.1.35","article-title":"Renal effects of prostaglandins and cyclooxygenase-2 inhibitors","volume":"6","author":"Kim","year":"2008","journal-title":"Electr. Blood Press."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1681\/ASN.V718","article-title":"Functional and molecular aspects of renal prostaglandin receptors","volume":"7","author":"Breyer","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00496848","article-title":"Renal prostaglandins: relationship to the development of blood pressure and concentrating capacity in preterm and full term healthy infants","volume":"132","author":"Joppich","year":"1979","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0280","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1146\/annurev.pharmtox.41.1.661","article-title":"Prostanoid receptors: subtypes and signaling","volume":"41","author":"Breyer","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.10.004_bib0285","doi-asserted-by":"crossref","first-page":"F235","DOI":"10.1152\/ajprenal.00454.2004","article-title":"Prostacyclin signaling in the kidney: implications for health and disease","volume":"289","author":"Nasrallah","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.10.004_bib0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI200113455","article-title":"Genetic and pharmacological analysis of prostanoid receptor function","volume":"108","author":"Narumiya","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.10.004_bib0295","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MNH.0b013e32834d9d75","article-title":"The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function","volume":"21","author":"Green","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.prostaglandins.2017.10.004_bib0300","doi-asserted-by":"crossref","first-page":"F310","DOI":"10.1152\/ajprenal.2000.278.2.F310","article-title":"Aquaporin-4 is expressed in basolateral membranes of proximal tubule S3 segments in mouse kidney","volume":"278","author":"van Hoek","year":"2000","journal-title":"Am. J. Phsyiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.10.004_bib0305","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.3892\/mmr.2015.4209","article-title":"Expression pattern of aquaporins in patients with primary nephrotic syndrome with edema","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:00:44Z","timestamp":1761098444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882317300588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":61,"alternative-id":["S1098882317300588"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.10.004","relation":{},"ISSN":["1098-8823"],"issn-type":[{"type":"print","value":"1098-8823"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermittent hypoxia alters dose dependent caffeine effects on renal prostanoids and receptors in neonatal rats","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}